Now, researchers have developed an online decision-making tool to help patients understand the implants and boost their ...
A research team led by Prof. Hesheng Liu, founder and Chief Scientific Officer of Galaxy Brain Scientific Inc., has published ...
8hon MSN
Cerebrospinal fluid biomarker improves diagnosis of Parkinson's disease and Lewy body dementia
An international consortium has achieved a major breakthrough in the diagnosis of neurological diseases. In a recent ...
More than 200,000 Australians could benefit from breakthroughs on a debilitating neurological disorder under a new national ...
A Finnish clinical imaging study shows that rest tremor in Parkinson's disease is not explained by greater dopamine loss.
Why do we lose our balance as we age? New research shows that Parkinson's and aging cause the brain to over-engage during balance recovery, leading to muscle stiffness and increased fall risk. Learn ...
Oryon Cell Therapies ("Oryon"), a clinical-stage biotechnology company focused on developing autologous neuron replacement medicines for Parkinson's disease and other neurodegenerative disorders, ...
When it comes to balance, more effort from the brain and muscles may actually mean less control—and a higher risk of falling.
Tiny plastic particles may be quietly threatening brain health. New research suggests microplastics—now widely found in food, ...
Can a spinal fluid test diagnose Parkinson’s? Researchers have identified DOPA decarboxylase as a key biomarker that separates Parkinson’s and Lewy body dementia from other forms of cognitive decline.
Long term exposure to the pesticide chlorpyrifos linked to higher Parkinson’s risk and brain damage, study finds strong evidence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results